Perrigo (PRGO) Other Working Capital Changes (2013 - 2026)
Perrigo's (PRGO) quarterly Other Working Capital Changes came in at -$3.2 million in Q1 2026, down 150.0% year-on-year from $6.4 million in Q1 2025, and down 128.57% on a QoQ basis from -$1.4 million in Q4 2025.
Perrigo (PRGO) Other Working Capital Changes (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has 14 years of Other Working Capital Changes data on file, last reported at -$3.2 million in Q1 2026.
- On a quarterly basis, Other Working Capital Changes fell 150.0% year-over-year to -$3.2 million in Q1 2026; TTM through Mar 2026 was -$35.8 million, a 1888.89% decrease from a year earlier, with the FY2025 full-year figure at -$26.2 million, down 2.34% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$3.2 million, down from -$1.4 million in the prior quarter.
- Over the last five years, Other Working Capital Changes for PRGO reached as high as $196.3 million in Q1 2026 and fell as low as -$228.2 million in Q3 2025.
- Historically, Other Working Capital Changes has averaged $12.3 million across 5 years, with a median of $11.7 million in 2024.
- On a YoY basis, Other Working Capital Changes climbed as much as 6900.0% in 2023 and fell as far as 757.32% in 2023.
- Year by year, Other Working Capital Changes stood at $7.8 million in 2022, then sank by 191.03% to -$7.1 million in 2023, then jumped by 36.62% to -$4.5 million in 2024, then surged by 68.89% to -$1.4 million in 2025, then slumped by 128.57% to -$3.2 million in 2026.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were -$3.2 million in Q1 2026, -$1.4 million in Q4 2025, and -$15.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Perrigo | 1.40 Bn | 1.05 Bn | 325.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 196.30 Mn |
| Mar 28, 2026 | 196.30 Mn |
| Mar 28, 2026 | 196.30 Mn |
| Dec 31, 2025 | 114.70 Mn |
| Dec 31, 2025 | 114.70 Mn |
| Dec 31, 2025 | 114.70 Mn |
| Sep 27, 2025 | -228.20 Mn |
| Sep 27, 2025 | -228.20 Mn |
| Sep 27, 2025 | -228.20 Mn |
| Jun 28, 2025 | 35.20 Mn |
| Jun 28, 2025 | 35.20 Mn |
| Jun 28, 2025 | 35.20 Mn |
| Mar 29, 2025 | 179.40 Mn |
| Mar 29, 2025 | 179.40 Mn |
| Mar 29, 2025 | 179.40 Mn |
| Dec 31, 2024 | -19.60 Mn |
| Dec 31, 2024 | -19.60 Mn |
| Dec 31, 2024 | -19.60 Mn |
| Sep 28, 2024 | 11.70 Mn |
| Sep 28, 2024 | 11.70 Mn |